nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNB1—pulmonary artery—chronic obstructive pulmonary disease	0.0678	0.227	CbGeAlD
Dalfampridine—KCNA5—pulmonary artery—chronic obstructive pulmonary disease	0.0446	0.149	CbGeAlD
Dalfampridine—KCNS3—pulmonary artery—chronic obstructive pulmonary disease	0.0437	0.146	CbGeAlD
Dalfampridine—KCNA10—respiratory system—chronic obstructive pulmonary disease	0.0205	0.0685	CbGeAlD
Dalfampridine—KCNA10—lung—chronic obstructive pulmonary disease	0.0109	0.0364	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00918	0.0307	CbGeAlD
Dalfampridine—Pharyngolaryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.00888	0.0201	CcSEcCtD
Dalfampridine—Laryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.0088	0.0199	CcSEcCtD
Dalfampridine—KCNG2—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00874	0.0337	CbGpPWpGaD
Dalfampridine—KCNS3—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00874	0.0337	CbGpPWpGaD
Dalfampridine—KCNB1—Glucagon-like Peptide-1 (GLP1) regulates insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00828	0.0319	CbGpPWpGaD
Dalfampridine—KCNF1—bronchus—chronic obstructive pulmonary disease	0.0069	0.0231	CbGeAlD
Dalfampridine—KCNA5—connective tissue—chronic obstructive pulmonary disease	0.0066	0.0221	CbGeAlD
Dalfampridine—KCNA5—bronchus—chronic obstructive pulmonary disease	0.00618	0.0207	CbGeAlD
Dalfampridine—KCNS3—bronchus—chronic obstructive pulmonary disease	0.00605	0.0202	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—chronic obstructive pulmonary disease	0.00604	0.0202	CbGeAlD
Dalfampridine—KCNA3—lung—chronic obstructive pulmonary disease	0.00572	0.0191	CbGeAlD
Dalfampridine—KCND3—respiratory system—chronic obstructive pulmonary disease	0.00558	0.0187	CbGeAlD
Dalfampridine—KCNA5—trachea—chronic obstructive pulmonary disease	0.00554	0.0185	CbGeAlD
Dalfampridine—KCNS3—trachea—chronic obstructive pulmonary disease	0.00543	0.0182	CbGeAlD
Dalfampridine—KCNQ1—respiratory system—chronic obstructive pulmonary disease	0.00541	0.0181	CbGeAlD
Dalfampridine—KCNC2—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00538	0.0207	CbGpPWpGaD
Dalfampridine—KCNG2—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00538	0.0207	CbGpPWpGaD
Dalfampridine—KCNS3—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00538	0.0207	CbGpPWpGaD
Dalfampridine—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00533	0.0121	CcSEcCtD
Dalfampridine—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00533	0.0121	CcSEcCtD
Dalfampridine—KCND1—lung—chronic obstructive pulmonary disease	0.0052	0.0174	CbGeAlD
Dalfampridine—KCNC4—lung—chronic obstructive pulmonary disease	0.0052	0.0174	CbGeAlD
Dalfampridine—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00518	0.0117	CcSEcCtD
Dalfampridine—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00516	0.0117	CcSEcCtD
Dalfampridine—KCNB1—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.0051	0.0197	CbGpPWpGaD
Dalfampridine—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00471	0.0107	CcSEcCtD
Dalfampridine—KCNF1—lung—chronic obstructive pulmonary disease	0.00445	0.0149	CbGeAlD
Dalfampridine—KCNQ1—bronchus—chronic obstructive pulmonary disease	0.00445	0.0149	CbGeAlD
Dalfampridine—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00432	0.00979	CcSEcCtD
Dalfampridine—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00432	0.00977	CcSEcCtD
Dalfampridine—KCNC2—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00423	0.0163	CbGpPWpGaD
Dalfampridine—KCNG2—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00423	0.0163	CbGpPWpGaD
Dalfampridine—KCNS3—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00423	0.0163	CbGpPWpGaD
Dalfampridine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00419	0.0095	CcSEcCtD
Dalfampridine—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00403	0.00913	CcSEcCtD
Dalfampridine—KCNB1—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00401	0.0155	CbGpPWpGaD
Dalfampridine—KCNA5—lung—chronic obstructive pulmonary disease	0.00398	0.0133	CbGeAlD
Dalfampridine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00391	0.00884	CcSEcCtD
Dalfampridine—KCNS3—lung—chronic obstructive pulmonary disease	0.0039	0.013	CbGeAlD
Dalfampridine—KCNQ3—lung—chronic obstructive pulmonary disease	0.0039	0.013	CbGeAlD
Dalfampridine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00381	0.00862	CcSEcCtD
Dalfampridine—KCNH6—lung—chronic obstructive pulmonary disease	0.00356	0.0119	CbGeAlD
Dalfampridine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00354	0.00801	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00352	0.00798	CcSEcCtD
Dalfampridine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00338	0.00765	CcSEcCtD
Dalfampridine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00334	0.00755	CcSEcCtD
Dalfampridine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0033	0.00748	CcSEcCtD
Dalfampridine—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00326	0.00738	CcSEcCtD
Dalfampridine—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00314	0.00711	CcSEcCtD
Dalfampridine—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00314	0.00711	CcSEcCtD
Dalfampridine—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00308	0.00697	CcSEcCtD
Dalfampridine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00308	0.00697	CcSEcCtD
Dalfampridine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00299	0.00678	CcSEcCtD
Dalfampridine—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00297	0.00672	CcSEcCtD
Dalfampridine—KCND3—lung—chronic obstructive pulmonary disease	0.00296	0.00991	CbGeAlD
Dalfampridine—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00296	0.0067	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00294	0.00665	CcSEcCtD
Dalfampridine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00291	0.00659	CcSEcCtD
Dalfampridine—KCNQ1—lung—chronic obstructive pulmonary disease	0.00287	0.0096	CbGeAlD
Dalfampridine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0028	0.00635	CcSEcCtD
Dalfampridine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00619	CcSEcCtD
Dalfampridine—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.00616	CcSEcCtD
Dalfampridine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00271	0.00615	CcSEcCtD
Dalfampridine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0027	0.00612	CcSEcCtD
Dalfampridine—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00265	0.006	CcSEcCtD
Dalfampridine—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00265	0.006	CcSEcCtD
Dalfampridine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00264	0.00597	CcSEcCtD
Dalfampridine—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.00596	CcSEcCtD
Dalfampridine—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00596	CcSEcCtD
Dalfampridine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0026	0.0059	CcSEcCtD
Dalfampridine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00574	CcSEcCtD
Dalfampridine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00251	0.00568	CcSEcCtD
Dalfampridine—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00248	0.00563	CcSEcCtD
Dalfampridine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00244	0.00553	CcSEcCtD
Dalfampridine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.00545	CcSEcCtD
Dalfampridine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.0024	0.00542	CcSEcCtD
Dalfampridine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00239	0.00541	CcSEcCtD
Dalfampridine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00239	0.00541	CcSEcCtD
Dalfampridine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00236	0.00534	CcSEcCtD
Dalfampridine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00234	0.0053	CcSEcCtD
Dalfampridine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00227	0.00514	CcSEcCtD
Dalfampridine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00511	CcSEcCtD
Dalfampridine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.0051	CcSEcCtD
Dalfampridine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00225	0.00509	CcSEcCtD
Dalfampridine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.00505	CcSEcCtD
Dalfampridine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00222	0.00504	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00222	0.00502	CcSEcCtD
Dalfampridine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00497	CcSEcCtD
Dalfampridine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00497	CcSEcCtD
Dalfampridine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00496	CcSEcCtD
Dalfampridine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00496	CcSEcCtD
Dalfampridine—KCNC4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00217	0.00838	CbGpPWpGaD
Dalfampridine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00216	0.0049	CcSEcCtD
Dalfampridine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00487	CcSEcCtD
Dalfampridine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00486	CcSEcCtD
Dalfampridine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.00486	CcSEcCtD
Dalfampridine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.00485	CcSEcCtD
Dalfampridine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00213	0.00483	CcSEcCtD
Dalfampridine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00482	CcSEcCtD
Dalfampridine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00482	CcSEcCtD
Dalfampridine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00213	0.00481	CcSEcCtD
Dalfampridine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.0048	CcSEcCtD
Dalfampridine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0021	0.00475	CcSEcCtD
Dalfampridine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00472	CcSEcCtD
Dalfampridine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00471	CcSEcCtD
Dalfampridine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00208	0.00471	CcSEcCtD
Dalfampridine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00469	CcSEcCtD
Dalfampridine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00468	CcSEcCtD
Dalfampridine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.00465	CcSEcCtD
Dalfampridine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00463	CcSEcCtD
Dalfampridine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00463	CcSEcCtD
Dalfampridine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00202	0.00458	CcSEcCtD
Dalfampridine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00455	CcSEcCtD
Dalfampridine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.002	0.00452	CcSEcCtD
Dalfampridine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00198	0.00449	CcSEcCtD
Dalfampridine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.00449	CcSEcCtD
Dalfampridine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00194	0.0044	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00194	0.00747	CbGpPWpGaD
Dalfampridine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00193	0.00438	CcSEcCtD
Dalfampridine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00438	CcSEcCtD
Dalfampridine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00438	CcSEcCtD
Dalfampridine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00438	CcSEcCtD
Dalfampridine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00435	CcSEcCtD
Dalfampridine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00429	CcSEcCtD
Dalfampridine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00426	CcSEcCtD
Dalfampridine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00424	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00185	0.00712	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00185	0.00712	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00418	CcSEcCtD
Dalfampridine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00183	0.00414	CcSEcCtD
Dalfampridine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00413	CcSEcCtD
Dalfampridine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00408	CcSEcCtD
Dalfampridine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.00408	CcSEcCtD
Dalfampridine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0018	0.00408	CcSEcCtD
Dalfampridine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00407	CcSEcCtD
Dalfampridine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00406	CcSEcCtD
Dalfampridine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00406	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00405	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00405	CcSEcCtD
Dalfampridine—KCNV2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00177	0.00683	CbGpPWpGaD
Dalfampridine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00398	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00175	0.00397	CcSEcCtD
Dalfampridine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00391	CcSEcCtD
Dalfampridine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00391	CcSEcCtD
Dalfampridine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00388	CcSEcCtD
Dalfampridine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00388	CcSEcCtD
Dalfampridine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00385	CcSEcCtD
Dalfampridine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00385	CcSEcCtD
Dalfampridine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00384	CcSEcCtD
Dalfampridine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00383	CcSEcCtD
Dalfampridine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00383	CcSEcCtD
Dalfampridine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00383	CcSEcCtD
Dalfampridine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00168	0.0038	CcSEcCtD
Dalfampridine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.0038	CcSEcCtD
Dalfampridine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00168	0.0038	CcSEcCtD
Dalfampridine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00167	0.00378	CcSEcCtD
Dalfampridine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00376	CcSEcCtD
Dalfampridine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00372	CcSEcCtD
Dalfampridine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00369	CcSEcCtD
Dalfampridine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00367	CcSEcCtD
Dalfampridine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00365	CcSEcCtD
Dalfampridine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00365	CcSEcCtD
Dalfampridine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00362	CcSEcCtD
Dalfampridine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00159	0.00531	CbGeAlD
Dalfampridine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00359	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00158	0.00609	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00357	CcSEcCtD
Dalfampridine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00354	CcSEcCtD
Dalfampridine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00354	CcSEcCtD
Dalfampridine—KCNG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00155	0.00597	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00155	0.00597	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00155	0.00597	CbGpPWpGaD
Dalfampridine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00349	CcSEcCtD
Dalfampridine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00349	CcSEcCtD
Dalfampridine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00346	CcSEcCtD
Dalfampridine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00345	CcSEcCtD
Dalfampridine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00344	CcSEcCtD
Dalfampridine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00344	CcSEcCtD
Dalfampridine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00344	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00151	0.00581	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00151	0.00581	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00151	0.00581	CbGpPWpGaD
Dalfampridine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.0034	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00338	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00338	CcSEcCtD
Dalfampridine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00337	CcSEcCtD
Dalfampridine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00334	CcSEcCtD
Dalfampridine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00334	CcSEcCtD
Dalfampridine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00334	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00147	0.00566	CbGpPWpGaD
Dalfampridine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00331	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00331	CcSEcCtD
Dalfampridine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00329	CcSEcCtD
Dalfampridine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00327	CcSEcCtD
Dalfampridine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00325	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00143	0.00553	CbGpPWpGaD
Dalfampridine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00324	CcSEcCtD
Dalfampridine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00324	CcSEcCtD
Dalfampridine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00322	CcSEcCtD
Dalfampridine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00322	CcSEcCtD
Dalfampridine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00322	CcSEcCtD
Dalfampridine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.0032	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00319	CcSEcCtD
Dalfampridine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00316	CcSEcCtD
Dalfampridine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00311	CcSEcCtD
Dalfampridine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00311	CcSEcCtD
Dalfampridine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00308	CcSEcCtD
Dalfampridine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00305	CcSEcCtD
Dalfampridine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00305	CcSEcCtD
Dalfampridine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00135	0.00305	CcSEcCtD
Dalfampridine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00304	CcSEcCtD
Dalfampridine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00304	CcSEcCtD
Dalfampridine—KCNQ1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00134	0.00518	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00134	0.00518	CbGpPWpGaD
Dalfampridine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00303	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00132	0.00508	CbGpPWpGaD
Dalfampridine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00293	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00129	0.00499	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00288	CcSEcCtD
Dalfampridine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00288	CcSEcCtD
Dalfampridine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00288	CcSEcCtD
Dalfampridine—KCNC2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00126	0.00487	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00126	0.00487	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00126	0.00487	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00282	CcSEcCtD
Dalfampridine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00281	CcSEcCtD
Dalfampridine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00281	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00123	0.00473	CbGpPWpGaD
Dalfampridine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00275	CcSEcCtD
Dalfampridine—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00121	0.00468	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00272	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0012	0.00461	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00119	0.00459	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00117	0.00452	CbGpPWpGaD
Dalfampridine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00265	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00115	0.00444	CbGpPWpGaD
Dalfampridine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00259	CcSEcCtD
Dalfampridine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00259	CcSEcCtD
Dalfampridine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00253	CcSEcCtD
Dalfampridine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00249	CcSEcCtD
Dalfampridine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00249	CcSEcCtD
Dalfampridine—KCND2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00109	0.00422	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00109	0.00422	CbGpPWpGaD
Dalfampridine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00247	CcSEcCtD
Dalfampridine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00247	CcSEcCtD
Dalfampridine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00246	CcSEcCtD
Dalfampridine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00246	CcSEcCtD
Dalfampridine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00245	CcSEcCtD
Dalfampridine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00245	CcSEcCtD
Dalfampridine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00244	CcSEcCtD
Dalfampridine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00243	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00107	0.00414	CbGpPWpGaD
Dalfampridine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00241	CcSEcCtD
Dalfampridine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00241	CcSEcCtD
Dalfampridine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00106	0.0024	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00106	0.00408	CbGpPWpGaD
Dalfampridine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00237	CcSEcCtD
Dalfampridine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00235	CcSEcCtD
Dalfampridine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00233	CcSEcCtD
Dalfampridine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00233	CcSEcCtD
Dalfampridine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00232	CcSEcCtD
Dalfampridine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00232	CcSEcCtD
Dalfampridine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00231	CcSEcCtD
Dalfampridine—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.00391	CbGpPWpGaD
Dalfampridine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.001	0.00227	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000998	0.00385	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000998	0.00385	CbGpPWpGaD
Dalfampridine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000993	0.00225	CcSEcCtD
Dalfampridine—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000976	0.00376	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000971	0.00374	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000971	0.00374	CbGpPWpGaD
Dalfampridine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000968	0.00219	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000967	0.00373	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000957	0.00369	CbGpPWpGaD
Dalfampridine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00094	0.00213	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000935	0.00212	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000924	0.00356	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000898	0.00346	CbGpPWpGaD
Dalfampridine—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000882	0.0034	CbGpPWpGaD
Dalfampridine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000868	0.00196	CcSEcCtD
Dalfampridine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000864	0.00196	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000848	0.00327	CbGpPWpGaD
Dalfampridine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000846	0.00192	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000845	0.00326	CbGpPWpGaD
Dalfampridine—CYP2E1—lung—chronic obstructive pulmonary disease	0.000843	0.00282	CbGeAlD
Dalfampridine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00084	0.0019	CcSEcCtD
Dalfampridine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000838	0.0019	CcSEcCtD
Dalfampridine—KCNQ3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000813	0.00314	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000813	0.00314	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000794	0.00306	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000771	0.00174	CcSEcCtD
Dalfampridine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000761	0.00172	CcSEcCtD
Dalfampridine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000743	0.00168	CcSEcCtD
Dalfampridine—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000737	0.00284	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00073	0.00282	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APIP—chronic obstructive pulmonary disease	0.00073	0.00282	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00073	0.00282	CbGpPWpGaD
Dalfampridine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000721	0.00163	CcSEcCtD
Dalfampridine—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000709	0.00273	CbGpPWpGaD
Dalfampridine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000706	0.0016	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000704	0.00159	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000692	0.00267	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000689	0.00156	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000679	0.00154	CcSEcCtD
Dalfampridine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000675	0.00153	CcSEcCtD
Dalfampridine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000666	0.00151	CcSEcCtD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000664	0.00256	CbGpPWpGaD
Dalfampridine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00066	0.00149	CcSEcCtD
Dalfampridine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000618	0.0014	CcSEcCtD
Dalfampridine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000615	0.00139	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00061	0.00138	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000603	0.00232	CbGpPWpGaD
Dalfampridine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000598	0.00135	CcSEcCtD
Dalfampridine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00059	0.00133	CcSEcCtD
Dalfampridine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000589	0.00133	CcSEcCtD
Dalfampridine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000586	0.00133	CcSEcCtD
Dalfampridine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000581	0.00132	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000562	0.00217	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00056	0.00127	CcSEcCtD
Dalfampridine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000555	0.00126	CcSEcCtD
Dalfampridine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00122	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000531	0.00205	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000527	0.00203	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.00201	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—chronic obstructive pulmonary disease	0.000518	0.002	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000501	0.00113	CcSEcCtD
Dalfampridine—KCNH2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000497	0.00192	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000491	0.00189	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000491	0.00189	CbGpPWpGaD
Dalfampridine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000488	0.0011	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000484	0.00186	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000484	0.00186	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000484	0.00186	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000479	0.00185	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000473	0.00182	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000471	0.00182	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GC—chronic obstructive pulmonary disease	0.000471	0.00181	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GC—chronic obstructive pulmonary disease	0.000471	0.00181	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GC—chronic obstructive pulmonary disease	0.000471	0.00181	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000459	0.00177	CbGpPWpGaD
Dalfampridine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000449	0.00102	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—GC—chronic obstructive pulmonary disease	0.000446	0.00172	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000437	0.00169	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000437	0.00169	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000437	0.00169	CbGpPWpGaD
Dalfampridine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000432	0.000978	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000431	0.00166	CbGpPWpGaD
Dalfampridine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000428	0.00097	CcSEcCtD
Dalfampridine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000428	0.000969	CcSEcCtD
Dalfampridine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000964	CcSEcCtD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00162	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000416	0.0016	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000415	0.0016	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000414	0.00159	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000405	0.00156	CbGpPWpGaD
Dalfampridine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000404	0.000914	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000399	0.00154	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000393	0.00152	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000393	0.00152	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.00146	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000351	0.00135	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000351	0.00135	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000342	0.00132	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000342	0.00132	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000332	0.00128	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00118	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—chronic obstructive pulmonary disease	0.000303	0.00117	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000302	0.00117	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000294	0.00113	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000276	0.00106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000257	0.000991	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000257	0.000991	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000257	0.000991	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000254	0.00098	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000254	0.00098	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000254	0.00098	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.000957	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000246	0.000948	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000244	0.00094	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000241	0.000929	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000232	0.000894	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000232	0.000894	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000232	0.000894	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000225	0.000868	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00022	0.000847	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000218	0.000842	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000218	0.000842	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000218	0.000842	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000216	0.000832	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000215	0.000829	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.000824	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.000824	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.000824	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.000781	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000197	0.000759	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000184	0.000709	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000184	0.000709	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000182	0.0007	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.0007	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00069	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000178	0.000687	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000178	0.000687	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000178	0.000687	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000176	0.000678	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000176	0.000678	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000176	0.000678	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000174	0.000672	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000169	0.000651	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000167	0.000642	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000165	0.000636	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000165	0.000636	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000164	0.000631	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000164	0.000631	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000164	0.000631	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000155	0.000598	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.000598	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.000598	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.000598	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000151	0.000584	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000149	0.000576	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000149	0.000573	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000149	0.000573	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000148	0.000569	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.000567	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000139	0.000536	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000137	0.000529	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.000508	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000131	0.000506	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000131	0.000506	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.000501	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000126	0.000487	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000118	0.000454	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000118	0.000454	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000114	0.00044	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000114	0.00044	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000108	0.000417	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000108	0.000417	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000106	0.000409	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000106	0.000409	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000106	0.000409	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000106	0.000407	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—chronic obstructive pulmonary disease	0.000106	0.000407	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000106	0.000407	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000102	0.000393	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000101	0.000389	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000101	0.000389	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000101	0.000389	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000101	0.000389	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000101	0.000389	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—chronic obstructive pulmonary disease	0.0001	0.000386	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.57e-05	0.000369	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.15e-05	0.000314	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.15e-05	0.000314	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.03e-05	0.000271	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	6.84e-05	0.000264	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.36e-05	0.000245	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.73e-05	0.000144	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.69e-05	0.000142	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.37e-05	0.00013	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.00012	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.59e-05	9.98e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.55e-05	9.84e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.38e-05	9.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-05	8.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.53e-05	5.91e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-05	5.65e-05	CbGpPWpGaD
